Fusion Pharmaceuticalsinc Stock Today
| FUSN Stock | USD 21.42 0.02 0.09% |
Performance9 of 100
| Odds Of DistressLess than 19
|
Fusion PharmaceuticalsI is selling at 21.42 as of the 27th of April 2024; that is 0.09 percent increase since the beginning of the trading day. The stock's open price was 21.4. Fusion PharmaceuticalsI has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Fusion PharmaceuticalsInc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of March 2024 and ending today, the 27th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 14th of March 2016 | Category Healthcare | Classification Health Care |
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada. Fusion Pharmaceuticals is traded on NASDAQ Exchange in the United States.. The company has 84.86 M outstanding shares of which 4.86 M shares are currently shorted by private and institutional investors with about 1.12 trading days to cover. More on Fusion PharmaceuticalsInc
Moving together with Fusion Stock
| 0.81 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
Moving against Fusion Stock
| 0.68 | IPSC | Century Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.67 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.48 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Fusion Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fusion PharmaceuticalsI's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fusion PharmaceuticalsI or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Officer | Mohit Rawat | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Fusion PharmaceuticalsI report their recommendations after researching Fusion PharmaceuticalsI's financial statements, talking to executives and customers, or listening in on Fusion PharmaceuticalsI's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Fusion PharmaceuticalsInc. The Fusion consensus assessment is calculated by taking the average forecast from all of the analysts covering Fusion PharmaceuticalsI. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators obtained from Fusion PharmaceuticalsI's historical financial statements, Fusion PharmaceuticalsInc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Fusion PharmaceuticalsInc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fusion PharmaceuticalsI's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Fusion PharmaceuticalsI's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Fusion PharmaceuticalsI's financial leverage. It provides some insight into what part of Fusion PharmaceuticalsI's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fusion PharmaceuticalsInc (FUSN) is traded on NASDAQ Exchange in USA. It is located in 270 Longwood Road South, Hamilton, ON, Canada, L8P 0A6 and employs 101 people. Fusion PharmaceuticalsI is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fusion PharmaceuticalsI's market, we take the total number of its shares issued and multiply it by Fusion PharmaceuticalsI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fusion PharmaceuticalsInc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 84.86 M outstanding shares of which 4.86 M shares are currently shorted by private and institutional investors with about 1.12 trading days to cover.
Fusion PharmaceuticalsInc currently holds about 198.42 M in cash with (81.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57.
Check Fusion PharmaceuticalsI Probability Of Bankruptcy
Ownership AllocationFusion PharmaceuticalsI holds a total of 84.86 Million outstanding shares. The majority of Fusion PharmaceuticalsInc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Fusion PharmaceuticalsInc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Fusion PharmaceuticalsI. Please pay attention to any change in the institutional holdings of Fusion PharmaceuticalsInc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fusion Ownership Details
Fusion Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Fusion PharmaceuticalsI jumping above the current price in 90 days from now is about 10.75%. The Fusion PharmaceuticalsInc probability density function shows the probability of Fusion PharmaceuticalsI stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.0297. This usually indicates Fusion PharmaceuticalsInc market returns are highly reactive to returns on the market. As the market goes up or down, Fusion PharmaceuticalsI is expected to follow. Moreover, fusion PharmaceuticalsInc has an alpha of 1.6189, implying that it can generate a 1.62 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Fusion PharmaceuticalsI to move above the current price in 90 days from now is about 10.75 (This Fusion PharmaceuticalsInc probability density function shows the probability of Fusion Stock to fall within a particular range of prices over 90 days) .
Fusion Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Fusion PharmaceuticalsI that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Fusion PharmaceuticalsI's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Fusion PharmaceuticalsI's value.| Instituion | Recorded On | Shares | |
| Sphera Funds Management Ltd. | 2023-12-31 | 1.1 M | |
| Artal Group S A | 2023-12-31 | 1 M | |
| Blair William & Co | 2023-12-31 | 993.9 K | |
| Wellington Management Company Llp | 2023-12-31 | 744.5 K | |
| 1832 Asset Management L.p | 2023-12-31 | 734.3 K | |
| Eagle Health Investments Lp | 2023-12-31 | 579.8 K | |
| Millennium Management Llc | 2023-12-31 | 578.1 K | |
| Ikarian Capital, Llc | 2023-12-31 | 500 K | |
| Blackrock Inc | 2023-12-31 | 419.8 K | |
| Federated Hermes Inc | 2023-12-31 | 10.9 M | |
| Avidity Partners Management Lp | 2023-12-31 | 6.5 M |
Fusion PharmaceuticalsI Historical Income Statement
Fusion PharmaceuticalsInc Income Statement is one of the three primary financial statements used for reporting Fusion's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Fusion PharmaceuticalsInc revenue and expense. Fusion PharmaceuticalsI Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Fusion PharmaceuticalsI's Total Other Income Expense Net is very stable compared to the past year. As of the 27th of April 2024, Income Tax Expense is likely to grow to about 826.4 K, though Tax Provision is likely to grow to (806.5 K). View More FundamentalsFusion Stock Against Markets
Picking the right benchmark for Fusion PharmaceuticalsI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Fusion PharmaceuticalsI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Fusion PharmaceuticalsI is critical whether you are bullish or bearish towards Fusion PharmaceuticalsInc at a given time. Please also check how Fusion PharmaceuticalsI's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fusion PharmaceuticalsI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Fusion PharmaceuticalsI Corporate Management
Elected by the shareholders, the Fusion PharmaceuticalsI's board of directors comprises two types of representatives: Fusion PharmaceuticalsI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fusion. The board's role is to monitor Fusion PharmaceuticalsI's management team and ensure that shareholders' interests are well served. Fusion PharmaceuticalsI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fusion PharmaceuticalsI's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Leamon | Chief Officer | Profile | |
| John Valliant | CEO Founder | Profile | |
| Eric Hoffman | Senior Development | Profile | |
| Dmitri MD | Chief Officer | Profile | |
| Maria Stahl | Chief Officer | Profile | |
| Victor Paulus | VP Affairs | Profile |
How to buy Fusion Stock?
Before investing in Fusion PharmaceuticalsI, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Fusion PharmaceuticalsI. To buy Fusion PharmaceuticalsI stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Fusion PharmaceuticalsI. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Fusion PharmaceuticalsI stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Fusion PharmaceuticalsInc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Fusion PharmaceuticalsInc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Fusion PharmaceuticalsInc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Fusion Stock please use our How to Invest in Fusion PharmaceuticalsI guide.
Already Invested in Fusion PharmaceuticalsInc?
The danger of trading Fusion PharmaceuticalsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Fusion PharmaceuticalsI is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Fusion PharmaceuticalsI. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Fusion PharmaceuticalsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Fusion PharmaceuticalsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fusion PharmaceuticalsI's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fusion Pharmaceuticalsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fusion Pharmaceuticalsinc Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Fusion Stock analysis
When running Fusion PharmaceuticalsI's price analysis, check to measure Fusion PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusion PharmaceuticalsI is operating at the current time. Most of Fusion PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Fusion PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusion PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Fusion PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Fusion PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion PharmaceuticalsI. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.45) | Revenue Per Share 0.032 | Quarterly Revenue Growth (1.00) | Return On Assets (0.25) | Return On Equity (0.49) |
The market value of Fusion PharmaceuticalsInc is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Fusion PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Fusion PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.